These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 12370832)
21. The carboxy terminus of p53 mimics the polylysine effect of protein kinase CK2-catalyzed MDM2 phosphorylation. Guerra B; Götz C; Wagner P; Montenarh M; Issinger OG Oncogene; 1997 Jun; 14(22):2683-8. PubMed ID: 9178766 [TBL] [Abstract][Full Text] [Related]
22. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells. Park US; Park SK; Lee YI; Park JG; Lee YI Oncogene; 2000 Jul; 19(30):3384-94. PubMed ID: 10918595 [TBL] [Abstract][Full Text] [Related]
23. An acetylation switch in p53 mediates holo-TFIID recruitment. Li AG; Piluso LG; Cai X; Gadd BJ; Ladurner AG; Liu X Mol Cell; 2007 Nov; 28(3):408-21. PubMed ID: 17996705 [TBL] [Abstract][Full Text] [Related]
24. UV-radiation induces dose-dependent regulation of p53 response and modulates p53-HDM2 interaction in human fibroblasts. Latonen L; Taya Y; Laiho M Oncogene; 2001 Oct; 20(46):6784-93. PubMed ID: 11709713 [TBL] [Abstract][Full Text] [Related]
25. Increased mdm-2 expression in a p53-independent manner blocks UV-induced cell cycle arrest and apoptosis in human osteosarcoma cells. Dong YB; Yang HL; Elliott MJ; McMasters KM Tumour Biol; 2003; 24(3):130-9. PubMed ID: 14610316 [TBL] [Abstract][Full Text] [Related]
26. p53 regulates Stat3 phosphorylation and DNA binding activity in human prostate cancer cells expressing constitutively active Stat3. Lin J; Tang H; Jin X; Jia G; Hsieh JT Oncogene; 2002 May; 21(19):3082-8. PubMed ID: 12082540 [TBL] [Abstract][Full Text] [Related]
27. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Momand J; Zambetti GP; Olson DC; George D; Levine AJ Cell; 1992 Jun; 69(7):1237-45. PubMed ID: 1535557 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of p53-dependent transcription by BOX-I phospho-peptide mimetics that bind to p300. Dornan D; Hupp TR EMBO Rep; 2001 Feb; 2(2):139-44. PubMed ID: 11258706 [TBL] [Abstract][Full Text] [Related]
29. Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2. Dumaz N; Meek DW EMBO J; 1999 Dec; 18(24):7002-10. PubMed ID: 10601022 [TBL] [Abstract][Full Text] [Related]
30. Limited role of N-terminal phosphoserine residues in the activation of transcription by p53. Jackson MW; Agarwal MK; Agarwal ML; Agarwal A; Stanhope-Baker P; Williams BR; Stark GR Oncogene; 2004 May; 23(25):4477-87. PubMed ID: 15064747 [TBL] [Abstract][Full Text] [Related]
31. The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression. Venot C; Maratrat M; Dureuil C; Conseiller E; Bracco L; Debussche L EMBO J; 1998 Aug; 17(16):4668-79. PubMed ID: 9707426 [TBL] [Abstract][Full Text] [Related]
32. Regulation of the accumulation and function of p53 by phosphorylation of two residues within the domain that binds to Mdm2. Bean LJ; Stark GR J Biol Chem; 2002 Jan; 277(3):1864-71. PubMed ID: 11707453 [TBL] [Abstract][Full Text] [Related]
33. [Gastric cancer and tumor growth regulation. Study of cell proliferation markers and protein complex p53/p21WAF1/CIP1/mdm-2]. Villaseca M; Araya JC; Roa I; Roa JC Rev Med Chil; 2000 Feb; 128(2):127-36. PubMed ID: 10962880 [TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical expression of p53, bcl-2, mdm2 and waf1/p21 proteins in colorectal adenocarcinomas. Valassiadou KE; Stefanaki K; Tzardi M; Datseris G; Georgoulias V; Melissas J; Tsiftsis DD; Delides G; Kanavaros P Anticancer Res; 1997; 17(4A):2571-6. PubMed ID: 9252682 [TBL] [Abstract][Full Text] [Related]
35. p21WAF1/CIP1 and MDM2 expression in non-Hodgkin's lymphoma and their relationship to p53 status: a p53+, MDM2-, p21-immunophenotype associated with missense p53 mutations. Villuendas R; Pezzella F; Gatter K; Algara P; Sánchez-Beato M; Martínez P; Martínez JC; Muñoz K; García P; Sánchez L; Kocialkowsky S; Campo E; Orradre JL; Piris MA J Pathol; 1997 Jan; 181(1):51-61. PubMed ID: 9072003 [TBL] [Abstract][Full Text] [Related]
36. P21/waf1 protein expression in nasopharyngeal carcinoma. Comparative study with PCNA, p53 and MDM-2 protein expression. Kouvidou C; Stefanaki K; Dai Y; Tzardi M; Koutsoubi K; Darivianaki K; Karidi E; Rontogianni D; Zois E; Kakolyris S; Georgoulias V; Delides G; Kanavaros P Anticancer Res; 1997; 17(4A):2615-9. PubMed ID: 9252690 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of transcription results in accumulation of Wt p53 followed by delayed outburst of p53-inducible proteins: p53 as a sensor of transcriptional integrity. Blagosklonny MV; Demidenko ZN; Fojo T Cell Cycle; 2002 Jan; 1(1):67-74. PubMed ID: 12429911 [TBL] [Abstract][Full Text] [Related]
38. Discordance between accumulated p53 protein level and its transcriptional activity in response to u.v. radiation. Lu X; Burbidge SA; Griffin S; Smith HM Oncogene; 1996 Jul; 13(2):413-8. PubMed ID: 8710381 [TBL] [Abstract][Full Text] [Related]
39. Rescue of mutant p53 transcription function by ellipticine. Peng Y; Li C; Chen L; Sebti S; Chen J Oncogene; 2003 Jul; 22(29):4478-87. PubMed ID: 12881704 [TBL] [Abstract][Full Text] [Related]
40. Activation of p53 transcriptional activity by 1,10-phenanthroline, a metal chelator and redox sensitive compound. Sun Y; Bian J; Wang Y; Jacobs C Oncogene; 1997 Jan; 14(4):385-93. PubMed ID: 9053835 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]